Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22)

Hematol J. 2003;4(3):218-21. doi: 10.1038/sj.thj.6200225.

Abstract

We describe a case of acute myeloid leukemia (AML) with t(8;21) in which complete remission (CR) was obtained with G-CSF given at 10 microg/kg in the absence of concomitant cytotoxic chemotherapy. CR was achieved following 2 weeks of therapy and confirmed by investigating minimal residual disease by four-color flow cytometry analysis. During treatment with G-CSF, maturing cells with cytoplasmic Auer Rods were observed in the peripheral blood, suggesting a differentiation effect. This case adds further evidence for a specific role of G-CSF in the treatment of AML with t(8;21), namely in patients who are not eligible for aggressive chemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Bone Marrow / pathology
  • Chromosomes, Human, Pair 21
  • Chromosomes, Human, Pair 8
  • Female
  • Flow Cytometry
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Immunophenotyping
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / genetics
  • Middle Aged
  • Molecular Diagnostic Techniques
  • Remission Induction
  • Salvage Therapy
  • Translocation, Genetic
  • Treatment Outcome

Substances

  • Granulocyte Colony-Stimulating Factor